Cardiovascular Systems, Inc. to Participate at SVB Leerink 2022 Global Healthcare Conference
January 27 2022 - 7:00AM
Business Wire
Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical
device company developing and commercializing innovative
interventional treatment systems for patients with peripheral and
coronary artery disease, today announced that management plans to
present and host investor meetings at the SVB Leerink 2022 Global
Healthcare Conference on February 18th. A webcast of the
presentation will be made available here.
SVB Leerink 2022 Global Healthcare Conference Friday, February
18, 2022 12:00 p.m. ET
About Cardiovascular Systems, Inc.
Cardiovascular Systems, Inc., based in St. Paul, Minn., is a
medical device company focused on developing and commercializing
innovative solutions for treating vascular and coronary disease.
The company’s orbital atherectomy system treats calcified and
fibrotic plaque in arterial vessels throughout the leg and heart
and addresses many of the limitations associated with existing
surgical, catheter and pharmacological treatment alternatives. For
additional information, please visit www.csi360.com and connect on
Twitter @csi360.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220127005014/en/
Cardiovascular Systems, Inc. Jack Nielsen Vice President,
Investor Relations & Corporate Communications (651) 202-4919
j.nielsen@csi360.com
Cardiovascular Systems (NASDAQ:CSII)
Historical Stock Chart
From Jun 2024 to Jul 2024
Cardiovascular Systems (NASDAQ:CSII)
Historical Stock Chart
From Jul 2023 to Jul 2024